kl003
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 23, 2023 (NCT05860595)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06280378 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2024 | Kanglin Biotech (Hangzhou) Co. LTD |
| NCT06219239 | N/A | Jan 4, 2024 | China Academy of Chinese Medical Sciences |
| NCT05860595 | N/A | May 23, 2023 | China Academy of Chinese Medical Sciences, Kanglin Biotech (Hangzhou) Co. LTD |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| China Academy of Chinese Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2023 |
| Kanglin Biotech (Hangzhou) Co. LTD | For profit | 2 | 1 | 2 | 2023 |
2 organizations
Page 1 / 1